This work is licensed under the Creative Commons Attribution 4.0 International License.
Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. World Health Organization. Geneva: World Health Organization, 2021; 108 p. ISBN 978-92-4-002708-4 (print version) ISBN 978-92-4-002707-7 (electronic version). Available from: https://www.who.int/publications/i/item/9789240027077Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021World Health OrganizationGenevaWorld Health Organization2021108 p. ISBN 978-92-4-002708-4 (print version) ISBN 978-92-4-002707-7 (electronic version). Available from: https://www.who.int/publications/i/item/9789240027077Search in Google Scholar
Global health sector strategy on viral hepatitis 2016–2021: Towards ending viral hepatitis. World Health Organization. Geneva: World Health Organization, 2016; 53 p. WHO reference number: WHO/HIV/2016.06. Available from: https://www.who.int/publications/i/item/WHO-HIV-2016.06World Health OrganizationGenevaWorld Health Organization201653 p. WHO reference number: WHO/HIV/2016.06. Available from: https://www.who.int/publications/i/item/WHO-HIV-2016.06Search in Google Scholar
Progress report on HIV, viral hepatitis and sexually transmitted infections 2019: accountability for the global health sector strategies, 2016–2021. World Health Organization. Geneva : World Health Organization, 2019; 39 p. WHO Document number: WHO/CDS/HIV/19.7. Available from: https://apps.who.int/iris/handle/10665/324797World Health OrganizationGenevaWorld Health Organization201939 p. WHO Document number: WHO/CDS/HIV/19.7. Available from: https://apps.who.int/iris/handle/10665/324797Search in Google Scholar
Combating hepatitis B and C to reach elimination by 2030: advocacy brief. World Health Organization. Geneva: World Health Organization, 2016; 17 p. WHO document number: WHO/HIV/2016.04. Available from: https://apps.who.int/iris/handle/10665/206453World Health OrganizationGenevaWorld Health Organization201617 p. WHO document number: WHO/HIV/2016.04. Available from: https://apps.who.int/iris/handle/10665/206453Search in Google Scholar
Cox AL, El-Sayed MH, Kao JH, Lazarus JV, Lemoine M, Lok AS, et al. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020;17(9):533–42. doi: 10.1038/s41575-020-0332-6CoxALEl-SayedMHKaoJHLazarusJVLemoineMLokASProgress towards elimination goals for viral hepatitis20201795334210.1038/s41575-020-0332-6Open DOISearch in Google Scholar
Thomas DL. Global Elimination of Chronic Hepatitis. N Engl J Med. 2019;380(21):2041–50. doi: 10.1056/NEJMra1810477ThomasDLGlobal Elimination of Chronic Hepatitis20193802120415010.1056/NEJMra1810477Open DOISearch in Google Scholar
Bertoletti A, Kennedy PT. The immune tolerant phase of chronic HBV infection: new perspectives on an old concept. Cell Mol Immunol. 2015;12(3):258–63. doi: 10.1038/cmi.2014.79BertolettiAKennedyPTThe immune tolerant phase of chronic HBV infection: new perspectives on an old concept20151232586310.1038/cmi.2014.79Open DOISearch in Google Scholar
Khanam A, Chua JV, Kottilil S. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. Int J Mol Sci. 2021;22(11):5497. doi: 10.3390/ijms22115497KhanamAChuaJVKottililSImmunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression20212211549710.3390/ijms22115497Open DOISearch in Google Scholar
Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–99. doi: 10.1002/hep.29800TerraultNALokASFMcMahonBJChangKMHwangJPJonasMMUpdate on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance201867415609910.1002/hep.29800Open DOISearch in Google Scholar
Revill PA, Chisari FV, Block JM, Dandri M, Gehring AJ, Guo H, et al.; Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors; Zoulim F. A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol. 2019;4(7):545–558. doi: 10.1016/S2468-1253(19)30119-0. Erratum in: Lancet Gastroenterol Hepatol. 2019 Jul;4(7):e7. doi: doi: 10.1016/S2468-1253(19)30151-7RevillPAChisariFVBlockJMDandriMGehringAJGuoHMembers of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior AdvisorsZoulimFA global scientific strategy to cure hepatitis B20194754555810.1016/S2468-1253(19)30119-0Erratum in: Lancet Gastroenterol Hepatol. 2019 Jul;4(7):e7. doi: doi: 10.1016/S2468-1253(19)30151-7Open DOISearch in Google Scholar
Bhat SA, Kazim SN. HBV cccDNA-A culprit and stumbling block for the hepatitis B virus infection: its presence in hepatocytes perplexed the possible mission for a functional cure. ACS Omega. 2022;7(28):24066–81. doi: 10.1021/acsomega.2c02216BhatSAKazimSNHBV cccDNA-A culprit and stumbling block for the hepatitis B virus infection: its presence in hepatocytes perplexed the possible mission for a functional cure2022728240668110.1021/acsomega.2c02216Open DOISearch in Google Scholar
Revill PA, Penicaud C, Brechot C, Zoulim F. Meeting the challenge of eliminating chronic hepatitis B infection. Genes (Basel). 2019;10(4):260. doi: 10.3390/genes10040260RevillPAPenicaudCBrechotCZoulimFMeeting the challenge of eliminating chronic hepatitis B infection201910426010.3390/genes10040260Open DOISearch in Google Scholar
Lucifora J, Protzer U. Attacking hepatitis B virus cccDNA—the holy grail to hepatitis B cure. J Hepatol. 2016;64(1 Suppl):S41–S48. doi: 10.1016/j.jhep.2016.02.009LuciforaJProtzerUAttacking hepatitis B virus cccDNA—the holy grail to hepatitis B cure2016641 SupplS41S4810.1016/j.jhep.2016.02.009Open DOISearch in Google Scholar
Indolfi G, Abdel-Hady M, Bansal S, Debray D, Smets F, Czubkowski P, et al. Management of hepatitis B virus infection and prevention of hepatitis B virus reactivation in children with acquired immunodeficiencies or undergoing immune suppressive, cytotoxic, or biological modifier therapies. J Pediatr Gastroenterol Nutr. 2020;70(4):527–538. doi: 10.1097/MPG.0000000000002628IndolfiGAbdel-HadyMBansalSDebrayDSmetsFCzubkowskiPManagement of hepatitis B virus infection and prevention of hepatitis B virus reactivation in children with acquired immunodeficiencies or undergoing immune suppressive, cytotoxic, or biological modifier therapies202070452753810.1097/MPG.0000000000002628Open DOISearch in Google Scholar
Hepatitis B. pp. 401-28. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2018–2021 Report of the Committee on Infectious Diseases. Committee on Infectious Diseases, American Academy of Pediatrics. 31st Edition. Itasca, IL: American Academy of Pediatrics, 2018:401–28. ISBN 978-1-61002-146-3. doi: 10.1542/9781610021470 (book doi). doi: 10.1542/9781610021470-part03-hepatitis_b (chapter doi)Hepatitis B40128In:KimberlinDWBradyMTJacksonMALongSSeditors.Red Book: 2018–2021 Report of the Committee on Infectious Diseases.31st EditionItasca, ILAmerican Academy of Pediatrics201840128ISBN 978-1-61002-146-3. doi: 10.1542/9781610021470 (book doi). doi: 10.1542/9781610021470-part03-hepatitis_b (chapter doi)Open DOISearch in Google Scholar
El Agheb MO, Grange JD. Prévention de la transmission mèreenfant de l’hépatite B. (Prevention of mother to child transmission of hepatitis B). Pan Afr Med J. 2015;20:316. French. doi: 10.11604/pamj.2015.20.316.6193El AghebMOGrangeJDPrévention de la transmission mèreenfant de l’hépatite B. (Prevention of mother to child transmission of hepatitis B)201520316French10.11604/pamj.2015.20.316.6193Open DOISearch in Google Scholar
European Association for the Study of the Liver; Collaborators: Lampertico P, Agarwal K, Berg T, Buti M, Janssen HLA, Papatheodoridis G, et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug;67(2):370–398. doi: 10.1016/j.jhep.2017.03.021European Association for the Study of the Liver; CollaboratorsLamperticoPAgarwalKBergTButiMJanssenHLAPapatheodoridisGEASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection2017Aug67237039810.1016/j.jhep.2017.03.021Open DOISearch in Google Scholar
Croagh CM, Lubel JS. Natural history of chronic hepatitis B: phases in a complex relationship. World J Gastroenterol. 2014;20(30):10395–404. doi: 10.3748/wjg.v20.i30.10395CroaghCMLubelJSNatural history of chronic hepatitis B: phases in a complex relationship201420301039540410.3748/wjg.v20.i30.10395Open DOISearch in Google Scholar
Bortolotti F, Guido M, Bartolacci S, Cadrobbi P, Crivellaro C, Noventa F, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology. 2006;43(3):556–62. doi: 10.1002/hep.21077BortolottiFGuidoMBartolacciSCadrobbiPCrivellaroCNoventaFChronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study20064335566210.1002/hep.21077Open DOISearch in Google Scholar
Lu FT, Ni YH. Elimination of mother-to-infant transmission of hepatitis B virus: 35 years of experience. Pediatr Gastroenterol Hepatol Nutr. 2020;23(4):311–8. doi: 10.5223/pghn.2020.23.4.311LuFTNiYHElimination of mother-to-infant transmission of hepatitis B virus: 35 years of experience2020234311810.5223/pghn.2020.23.4.311Open DOISearch in Google Scholar
Komatsu H, Inui A, Fujisawa T. Pediatric hepatitis B treatment. Ann Transl Med. 2017;5(3):37. doi: 10.21037/atm.2016.11.52KomatsuHInuiAFujisawaTPediatric hepatitis B treatment2017533710.21037/atm.2016.11.52Open DOISearch in Google Scholar
Stinco M, Rubino C, Trapani S, Indolfi G. Treatment of hepatitis B virus infection in children and adolescents. World J Gastroenterol. 2021;27(36):6053–63. doi: 10.3748/wjg.v27.i36.6053StincoMRubinoCTrapaniSIndolfiGTreatment of hepatitis B virus infection in children and adolescents2021273660536310.3748/wjg.v27.i36.6053Open DOISearch in Google Scholar
Mysore KR, Leung DH. Hepatitis B and C. Clin Liver Dis. 2018;22(4):703–22. doi: 10.1016/j.cld.2018.06.002MysoreKRLeungDHHepatitis B and C20182247032210.1016/j.cld.2018.06.002Open DOISearch in Google Scholar
WHO guidelines on hepatitis B and C testing. World Health Organization. Geneva: World Health Organization, 2017; 170 p. ISBN 978-92-4-154998-1. Available from: https://www.who.int/publications/i/item/9789241549981World Health OrganizationGenevaWorld Health Organization2017170 p. ISBN 978-92-4-154998-1. Available from: https://www.who.int/publications/i/item/9789241549981Search in Google Scholar
Costa JM, Telehin D, Munteanu M, Kobryn T, Ngo Y, Thibault V, et al. HCV-GenoFibrotest: a combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis C. Clin Res Hepatol Gastroenterol. 2011;35(3):204–13. doi: 10.1016/j.clinre.2011.01.005CostaJMTelehinDMunteanuMKobrynTNgoYThibaultVHCV-GenoFibrotest: a combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis C20113532041310.1016/j.clinre.2011.01.005Open DOISearch in Google Scholar
Mărginean CO, Meliț LE, Săsăran MO. Elastography—a bona fide non-invasive method for assessing non-alcoholic fatty liver disease in children. Applied Sciences. 2021;11(7):3240. doi: 10.3390/app11073240MărgineanCOMelițLESăsăranMOElastography—a bona fide non-invasive method for assessing non-alcoholic fatty liver disease in children2021117324010.3390/app11073240Open DOISearch in Google Scholar
Rodriguez-Baez N, Murray KF, Kleiner DE, Ling SC, Rosenthal P, Carlin K, et al. Hepatic histology in treatment-naïve children with chronic hepatitis B infection living in the United States and Canada. J Pediatr Gastroenterol Nutr. 2020;71(1): 99–105. doi: 10.1097/MPG.0000000000002712Rodriguez-BaezNMurrayKFKleinerDELingSCRosenthalPCarlinKHepatic histology in treatment-naïve children with chronic hepatitis B infection living in the United States and Canada20207119910510.1097/MPG.0000000000002712Open DOISearch in Google Scholar
Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang MH, Thorne C, et al. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019;4(6):466–76. doi: 10.1016/S2468-1253(19)30042-1. Erratum in: Lancet Gastroenterol Hepatol. 2020;5(5):e4. doi: 10.1016/S2468-1253(20)30092-3IndolfiGEasterbrookPDusheikoGSiberryGChangMHThorneCHepatitis B virus infection in children and adolescents2019464667610.1016/S2468-1253(19)30042-1Erratum in: Lancet Gastroenterol Hepatol. 2020;5(5):e410.1016/S2468-1253(20)30092-3Open DOISearch in Google Scholar
Wong WWL, Pechivanoglou P, Wong J, Bielecki JM, Haines A, Erman A, et al. Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials. Syst Rev. 2019;8(1):207. doi: 10.1186/s13643-019-1126-1WongWWLPechivanoglouPWongJBieleckiJMHainesAErmanAAntiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials20198120710.1186/s13643-019-1126-1Open DOISearch in Google Scholar
Wei S, Hu M, Chen H, Xie Q, Wang P, Li H, et al. Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study. BMC Gastroenterol. 2022;22(1):387. doi: 10.1186/s12876-022-02471-yWeiSHuMChenHXieQWangPLiHEffectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study202222138710.1186/s12876-022-02471-yOpen DOISearch in Google Scholar
Li M, Sun F, Bi X, Lin Y, Yang L, Lu Y, et al. Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients. Virol Sin. 2022;37(3):390–7. doi: 10.1016/j.virs.2022.03.001LiMSunFBiXLinYYangLLuYConsolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients2022373390710.1016/j.virs.2022.03.001Open DOISearch in Google Scholar
Pan J, Wang H, Yao T, Liao X, Cheng H, Liangpunsakul S, et al. Clinical predictors of functional cure in children 1–6 years-old with chronic hepatitis B. J Clin Transl Hepatol. 2022;10(3):405–11. doi: 10.14218/JCTH.2021.00142PanJWangHYaoTLiaoXChengHLiangpunsakulSClinical predictors of functional cure in children 1–6 years-old with chronic hepatitis B20221034051110.14218/JCTH.2021.00142Open DOISearch in Google Scholar
Zhong YW, Shi YM, Chu F, Liu J, Shi C, Xu JJ, et al. Prediction for HBsAg seroconversion in children with chronic hepatitis B. BMC Infect Dis. 2021;21(1):1211. doi: 10.1186/s12879-021-06883-1ZhongYWShiYMChuFLiuJShiCXuJJPrediction for HBsAg seroconversion in children with chronic hepatitis B2021211121110.1186/s12879-021-06883-1Open DOISearch in Google Scholar
Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1–98. doi: 10.1007/s12072-015-9675-4.SarinSKKumarMLauGKAbbasZChanHLChenCJAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update201610119810.1007/s12072-015-9675-4Open DOISearch in Google Scholar
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. World Health Organization; Global HIV, Hepatitis and Sexually Transmitted Infections Programmes. Geneva, Switzerland : WHO, March 2015; XXX, 134 p. ISBN 978 92 4 154905 9. Available from: https://www.who.int/publications/i/item/9789241549059World Health Organization; Global HIV, Hepatitis and Sexually Transmitted Infections ProgrammesGeneva, SwitzerlandWHOMarch2015XXX, 134 p. ISBN 978 92 4 154905 9. Available from: https://www.who.int/publications/i/item/9789241549059Search in Google Scholar
NICE National Institute for Health and Care Excellence. Hepatitis B (chronic): diagnosis and management : clinical guideline. CG165. London, Manchester, UK: NICE, published June 2013, corrected January 2014, last updated October 2017; 36 p. Published 26 June 2013. Las Updated 20 October 2017. ISBN 978-1-4731-4724-9. Available from: https://www.nice.org.uk/guidance/cg165NICE National Institute for Health and Care ExcellenceLondon, Manchester, UKNICEpublished June 2013, corrected January 2014, last updated October 2017; 36 p. Published 26 June 2013. Las Updated 20 October 2017. ISBN 978-1-4731-4724-9. Available from: https://www.nice.org.uk/guidance/cg165Search in Google Scholar
Sokal EM, Paganelli M, Wirth S, Socha P, Vajro P, Lacaille F, Kelly D, Mieli-Vergani G; European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Hepatol. 2013 Oct;59(4):814–29. doi: 10.1016/j.jhep.2013.05.016SokalEMPaganelliMWirthSSochaPVajroPLacailleFKellyDMieli-VerganiGEuropean Society of Pediatric Gastroenterology, Hepatology and NutritionManagement of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition2013Oct5948142910.1016/j.jhep.2013.05.016Open DOISearch in Google Scholar